# Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms

> **NCT00405457** · PHASE4 · COMPLETED · sponsor: **Innovative Medical** · enrollment: 50 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Restasis, Optive Tears

## Key facts

- **NCT ID:** NCT00405457
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405457, "Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00405457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*